Study on better treatment for mouth melanoma
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study looks at a rare type of melanoma that starts in the mouth. It aims to improve how doctors stage the cancer and choose treatments based on its molecular features, which may lead to more personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of melanoma that started in the mouth (not on skin or elsewhere).
- You are 18 years or older.
- You are either already receiving or planning to get standard treatments like surgery, radiation, chemo, immunotherapy, or targeted therapy.
- You have complete medical records (including test results and imaging) or are willing to be followed long-term.
- You must give consent for prospective participation or your past data can be used under ethical rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether giving pembrolizumab (an immunotherapy) together with a targeted form of radiation can help after surgery for mucosal melanoma. It aims to lower the chance of the cancer coming back and improve outcomes in people whose tumor was removed.
This trial tests a combination of three drugs (pucotenlimab, lenvatinib, and temozolomide) given before surgery to shrink head and neck mucosal melanoma and improve outcomes. It is for people whose cancer can be surgically removed.
This study compares two approaches for early-stage mouth cancer: careful observation of the neck versus a preventive surgery to remove neck lymph nodes. The goal is to see which strategy works better to prevent cancer from spreading.
This trial studies how well two medicines—axitinib and nivolumab—work for people with advanced melanoma that starts in moist “mucosal” areas (like the mouth, nose, throat, or bowel). It may help shrink tumors and control the disease by boosting the immune system and targeting tumor growth.
This study looks at tissue and blood samples from people with mouth conditions that could become cancer or are already cancer. It aims to learn more about these conditions to improve diagnosis and treatment.
This study looks at the types of bacteria in the mouth (the microbiome) in people with oral squamous cell cancer and compares them to people without this cancer. It may help researchers understand what’s different in oral cancer and what could be useful for diagnosis or treatment planning.
Hear when a new Mucosal Melanoma of the Head and Neck trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.